Additional Positive Phase 3 Data Announced for Ready-to-Use Glucagon Autoinjector
If approved, it would be the first room temperature stable liquid glucagon in an autoinjector formulation.
Hypoglycemia
Dasiglucagon Is a Promising Treatment Option for Severe Hypoglycemia
Dasiglucagon was found to be an effective and safe treatment option for severe hypoglycemia in type 1 diabetes.
Hypoglycemia at End of Hospital Stay Linked to Readmission, Mortality in Diabetes
For patients with diabetes who are hospitalized, hypoglycemia or near-normal glucose values during the last 24 hours of hospitalization can lead to higher rates of 30-day readmission and mortality.
Approved Glucose Monitor Does Not Meet Regulatory Standards, May Overestimate Hypoglycemic Values
The MyGlucoHealth blood glucose meter did not meet regulatory standards and may overestimate values in the hypoglycemic range.
Wearable Device for Heart Rate Variability Can Detect Early Hypoglycemia
A wearable device that measures real-time heart rate variability can detect early signs of hypoglycemia in patients with type 1 diabetes.
Hypoglycemia Often Unrecognized by Older Adults With T1D
Blood sugar levels of older adults with type 1 diabetes are in the hypoglycemic range for more than an hour a day, and blood sugar levels of those with impaired hypoglycemia awareness may be in hypoglycemic range even longer.
Head-to-Head Comparison of Professional vs Personal CGM Systems in T1D
Professional and personal continuous glucose monitoring systems exhibit similar accuracy in both inpatient and home settings, with both having lower sensor performance during hypoglycemic episodes.
High Prevalence of Fasting-Evoked Hypoglycemia in Diabetes
About 17 percent of patients with diabetes report experiencing hypoglycemia when fasting for lab tests.
Hypoglycemia Following Antifungal Treatment in Patient With Type 1 Diabetes
“This is the first report of decreased insulin requirements in a patient with [T1D] correlating with micafungin administration,” noted the authors.
Ready-to-Use Glucagon Rescue Pen for Severe Hypoglycemia Under FDA Review
The NDA included findings from multiple Phase 3 trials evaluating the safety, efficacy, and utility of the Xeris glucagon rescue pen auto-injector to treat severe hypoglycemia vs currently available glucagon emergency kits in children, adolescents, and adults with type 1 diabetes.
Next post in Diabetes
